Find similar content

Source channel @githubtrending · Post #14745 · May 24

#python#allowlist#blocklist#disposable#domain#email#filter#hacktoberfest#pypi This resource provides a comprehensive, regularly updated list of disposable email domains used to block fake or temporary email addresses that people often use to spam or abuse online services. By using this list, you can prevent users from registering with throwaway emails, improving the quality and security of your user base. It offers easy integration examples in many programming languages, helping you quickly check if an email is disposable and reject it if needed. This keeps your system cleaner, reduces spam, and ensures users provide real, permanent emails for better communication and trust. The list is free to use and open for contributions, making it reliable and community-supported. https://github.com/disposable-email-domains/disposable-email-domains

Hashtags

#python #allowlist #blocklist #disposable #domain #email #filter #hacktoberfest #pypi

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment